In addition, TCGA data showed that RSU1P2 is high-expression in breast cancer, bladder cancer and prostate cancer (Supplementary Figure S6), it needs to be unraveled whether that RSU1P2 exerts the similar role in these cancer cells. Here, RSU1P2 is linked to urinary bladder cancer.